Skip to content
Screener

Veradermics MANE Q4 2024 earnings

Reported March 30, 2026

EPS-$1.06Beat by $0.75
EPS estimate-$1.81

Next report

Nov 10, 2026 (in 2 months)
EPS estimate-$0.59

Financials

Q4 2024

Income statement

See full
Operating income-$6.7M
Net income-$6.6M
EPS (diluted)-$9.26

Balance sheet

See full
Cash & equivalents$53.1M
Total equity-$48.5M-118%
Total assets$55.5M

Cash flow

See full
Operating cash flow-$5.9M
CapEx-
Free cash flow-$5.9M

Versus estimates

FAQ

When did Veradermics report Q4 2024 earnings?
Veradermics (MANE) reported Q4 2024 earnings on March 30, 2026.
What were Veradermics's Q4 2024 revenue and EPS?
Veradermics reported eps of $-1.06 for Q4 2024.
Did Veradermics beat estimates in Q4 2024?
EPS beat the consensus estimate of $-1.81 by $0.75.
Where can I find Veradermics's Q4 2024 SEC filings?
You can read the 8-K earnings release (0001827635-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.